Menu

Petros Pharmaceuticals, Inc. PTPI

Full chart Compare
Set alert

Price alert · PTPI

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 5, 2026, 4:00 PM EST

0.04 +0.04 +1,233.33%

After hours · Nov 5, 4:00 PM ET

0.0028 Day range 0.0034
0.002 52-week range 0.022
YTD
-62.50%
1 year
-84.21%

Revenue & Expenses

Other Income → Expenses: $3.92MExpenses → Selling, General & Admin: $8.75MExpenses → Research & Development: $2.62MExpenses → Other Operating Expenses: $10.21MExpenses → Interest Expense: $560.91KGross Profit → Expenses: $3.90MRevenue → Gross Profit: $3.90MRevenue → Cost of Revenue: $1.21MNet Loss → Expenses: $14.32MOther Income$3.92MGross Profit$3.90MNet Loss$14.32MCost of Revenue$1.21MExpenses$22.14MSelling, General & Admin$8.75MResearch & Development$2.62MOther Operating Expenses$10.21MInterest Expense$560.91KRevenue$5.11M

Latest period ending Dec 31, 2024 · select a line to chart its full history

PTPI annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
5.11M5.82M5.99M7.81M9.56M
3.90M4.19M3.70M6.21M5.51M
-17.68M-10.76M-19.92M-18.05M-17.28M
-14.32M-8.16M-20.04M-8.99M-20.59M
-83.50-158.75-242.00-206.25-962.50
PTPI annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
1.72M13.34M9.43M23.85M17.14M
10.64M33.80M32.42M67.39M69.85M
18.10M21.32M15.72M31.85M52.38M
-7.47M12.07M16.70M35.54M17.47M
PTPI annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-2.60M-7.63M-12.80M-11.86M-15.31M
-24.59K000-4.63K
-7.00M11.54M-1.62M18.57M30.30M
-24.59K000-4.63K
-9.63M3.91M-14.42M6.71M14.99M